Postural Drainage and PEP Technique in Community Acquired Pneumonia

Sponsor
Riphah International University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05356494
Collaborator
(none)
46
1
2
3.5
13

Study Details

Study Description

Brief Summary

Community-acquired pneumonia is acquired outside the hospital. Postural drainage is the positioning of a patient with an involved lung segment such that gravity has a maximal effect of facilitating the drainage of Broncho-pulmonary secretions from the tracheobronchial tree. It is based on the concept of gravity-assisted mobilization of secretions and transports it for removal. The objective of the study to find the effect of postural drainage and positive expiratory pressure techniques (PEP) to improve the air way clearance and breathing in pneumonia patients. This study will be a RCT and will be conducted in Services Hospital. The study will be completed within the duration of six month. Consecutive sampling study technique will be used to collect the data. The sample size of 46 patients will be taken. Patients will be divided into two groups. (Group A will be treated with postural drainage and Group B will be treated with positive expiratory pressure technique). Outcome measure will be taken on Pulse oximeter, incentive spirometer and chest X- Ray. A regular follow up visits to department and a final assessment was made at the end of four week. Data will be analyzed using SPSS software version 25. After assessing normality of data by Shapiro- Wilk test, it will be decided either parametric or non-parametric test will be use within a group or between two groups.

Condition or Disease Intervention/Treatment Phase
  • Other: Postural drainage
  • Other: Positive expiratory pressure
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparisons Effects of Postural Drainage and Positive Expiratory Pressure Technique in Community Acquired Pneumonia.
Anticipated Study Start Date :
May 15, 2022
Anticipated Primary Completion Date :
Jul 15, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: postural drainage

(Group A will be treated with postural drainage)

Other: Postural drainage
(Group A will be treated with postural drainage)

Experimental: positive expiratory pressure technique

(Group B will be treated with positive expiratory pressure technique).

Other: Positive expiratory pressure
(Group B will be treated with positive expiratory pressure technique).

Outcome Measures

Primary Outcome Measures

  1. INCENTIVE SPIROMETER [1 Last week]

    An incentive spirometer is a handheld device that helps your lungs recover after a surgery or lung illness. When you breathe from an incentive spirometer, a piston rises inside the device and measures the volume of your breath. A healthcare provider can set a target breath volume for you to hit.

  2. OXYGEN SATURATION [1 Last week]

    Oxygen saturation, or "O2 sates," indicates that amount of oxygen traveling through your body with your red blood cells. Normal oxygen saturation is usually between 95% and 100% for most health.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with community acquired pneumonia.

  • Clinically stable patients.

  • Both genders

  • Age 30 to 70 years

Exclusion Criteria:
  • Presence of any genetic disorders (cystic fibrosis).

  • Recent spinal / chest surgery

  • Cardiac issues

  • Fractures of vertebra caused by osteoporosis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Services Hospital, Lahore. Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Sidra Faisal, MS.CPPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05356494
Other Study ID Numbers:
  • REC/Lhr/22/0318 M Ahmad
First Posted:
May 2, 2022
Last Update Posted:
May 2, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 2, 2022